Pine Grove Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$771K Sell
667
-10
-1% -$11.8K 0.07% 113
2026
Q2
$810K Buy
677
+64
+10% +$65.4K 0.08% 105
2026
Q1
$564K Buy
613
+14
+2% +$14.2K 0.07% 111
2025
Q4
$644K Buy
+599
New +$573K 0.08% 105

Other funds holding LLY

Pine Grove Financial Group's LLY Position: Q3 2026 in Review

Pine Grove Financial Group reduced its Eli Lilly (LLY) stake by 1.5% in Q3 2026, selling an estimated $11.8K and leaving 667 shares worth $771K. The position accounts for 0.07% of the portfolio, ranked #113.

Pine Grove Financial Group first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $810K in Q2 2026. 1,509 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Pine Grove Financial Group held 667 shares of Eli Lilly worth $771K as of Q3 2026.
  • Pine Grove Financial Group sold 10 Eli Lilly shares in Q3 2026, an estimated $11.8K.
  • Eli Lilly made up 0.07% of Pine Grove Financial Group's portfolio in Q3 2026, its #113 holding.
  • Pine Grove Financial Group first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • Pine Grove Financial Group's Eli Lilly position peaked at $810K in Q2 2026.
  • 1,509 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Pine Grove Financial Group's 13F filing for Q3 2026, filed 13 Oct 2026.